Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedApr 15, 2026
DataAggregated Company Financials
Companies17
- 7D2.0%
- 3M-8.3%
- 1Y-12.1%
- YTD-6.5%
In the last week, the Healthcare industry is up 2.0%, with DiaSorin up 4.4%. In contrast, the industry has lost 12% in the last 12 months. Earnings are forecast to grow by 7.6% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 16 Apr 2026 | €19.3b | €9.1b | €1.0b | 21.6x | 18.6x | 2.1x |
| Sat, 14 Mar 2026 | €19.0b | €8.8b | €862.6m | 19.2x | 22x | 2.2x |
| Mon, 09 Feb 2026 | €20.9b | €8.8b | €886.9m | 21.5x | 23.5x | 2.4x |
| Wed, 07 Jan 2026 | €20.9b | €8.8b | €886.9m | 21.2x | 23.6x | 2.4x |
| Fri, 05 Dec 2025 | €20.3b | €8.8b | €886.9m | 19.5x | 22.9x | 2.3x |
| Sun, 02 Nov 2025 | €22.2b | €8.8b | €886.0m | 21.6x | 25.1x | 2.5x |
| Tue, 30 Sep 2025 | €21.9b | €8.7b | €895.4m | 21x | 24.5x | 2.5x |
| Thu, 28 Aug 2025 | €23.2b | €8.7b | €902.9m | 19.8x | 25.7x | 2.7x |
| Sat, 26 Jul 2025 | €24.6b | €8.6b | €941.3m | 20.8x | 26.2x | 2.9x |
| Mon, 23 Jun 2025 | €23.9b | €25.2b | €985.5m | 20x | 24.3x | 1x |
| Wed, 21 May 2025 | €22.9b | €25.2b | €985.5m | 16.5x | 23.2x | 0.9x |
| Fri, 18 Apr 2025 | €21.4b | €20.1b | €908.1m | 18.3x | 23.6x | 1.1x |
| Sun, 16 Mar 2025 | €22.9b | €19.6b | €796.0m | 21.2x | 28.8x | 1.2x |
| Tue, 11 Feb 2025 | €25.8b | €20.0b | €828.0m | 24x | 31.2x | 1.3x |
| Thu, 09 Jan 2025 | €25.0b | €8.0b | €834.7m | 22.8x | 30x | 3.1x |
| Sat, 07 Dec 2024 | €24.6b | €19.0b | €1.4b | 19.2x | 17.2x | 1.3x |
| Mon, 04 Nov 2024 | €24.8b | €18.9b | €1.4b | 16.4x | 18.1x | 1.3x |
| Wed, 02 Oct 2024 | €25.0b | €18.9b | €1.4b | 17.1x | 18.2x | 1.3x |
| Fri, 30 Aug 2024 | €26.1b | €18.9b | €1.4b | 15.1x | 18.9x | 1.4x |
| Sun, 28 Jul 2024 | €26.0b | €18.8b | €1.4b | 17.1x | 18.8x | 1.4x |
| Tue, 25 Jun 2024 | €26.2b | €18.8b | €1.4b | 16.6x | 19x | 1.4x |
| Thu, 23 May 2024 | €26.1b | €18.8b | €1.4b | 17.4x | 18.9x | 1.4x |
| Sat, 20 Apr 2024 | €25.2b | €18.7b | €1.4b | 19.5x | 18.3x | 1.3x |
| Mon, 18 Mar 2024 | €28.3b | €18.6b | €1.4b | 20.8x | 20.3x | 1.5x |
| Wed, 14 Feb 2024 | €24.6b | €18.6b | €1.4b | 18.6x | 17.7x | 1.3x |
| Fri, 12 Jan 2024 | €24.8b | €18.6b | €1.4b | 18.2x | 17.9x | 1.3x |
| Sun, 10 Dec 2023 | €23.5b | €18.6b | €1.4b | 18.3x | 16.9x | 1.3x |
| Tue, 07 Nov 2023 | €22.6b | €18.6b | €1.4b | 16.9x | 16.1x | 1.2x |
| Thu, 05 Oct 2023 | €22.4b | €17.3b | €1.1b | 14.6x | 19.6x | 1.3x |
| Sat, 02 Sep 2023 | €23.8b | €17.3b | €1.1b | 16x | 20.9x | 1.4x |
| Mon, 31 Jul 2023 | €24.6b | €7.7b | €861.1m | 15.3x | 28.6x | 3.2x |
| Wed, 28 Jun 2023 | €23.8b | €7.7b | €822.5m | 17.7x | 29x | 3.1x |
| Fri, 26 May 2023 | €24.1b | €7.7b | €822.5m | 22.9x | 29.3x | 3.1x |
| Sun, 23 Apr 2023 | €24.1b | €7.6b | €826.9m | 21.2x | 29.1x | 3.2x |
Price to Earnings Ratio
29.1x
Current Industry PE
- Investors are pessimistic on the Italian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 18.6x which is lower than its 3-year average PE of 22.4x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 8.0% per year over the last three years.
- Revenues for these companies have grown 6.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 5.12% | |
| Healthcare | 1.98% | |
| Life Sciences | 10.37% | |
| Medical Equipment | 7.42% | |
| Healthcare Services | 0.96% | |
| Pharma | 0% | 0 |
| Healthtech | -2.20% | |
| Biotech | -2.62% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.6x.
- Analysts are expecting annual earnings growth of 21.9%, which is higher than its past year's earnings growth of 7.9% per year.
- Investors are most pessimistic about the Biotech industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 23% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Biotech industry is expected to see its earnings decline by 131% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIA DiaSorin | €63.30 | 4.4% +€141.0m | -35.5% | PE21.6x | |
| GVS GVS | €4.16 | 9.6% +€68.4m | 2.5% | PE42.4x | |
| REC Recordati Industria Chimica e Farmaceutica | €50.00 | 0.6% +€65.4m | 3.1% | PE23x | |
| ELN EL.En | €13.20 | 3.4% +€34.5m | 69.4% | PE21.2x | |
| AMP Amplifon | €9.39 | 1.4% +€28.6m | -42.6% | PE22.6x |
